Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studies.
MacLachlan TK, Kronenberg S, Marshall N, Andrews L, Berens SJ, Brouta F, Fogal B, Freebern W, Herzyk D, Kamperschroer C, Kiessling A, Schneidkraut M, Maier C.
MacLachlan TK, et al. Among authors: schneidkraut m.
Regul Toxicol Pharmacol. 2021 Feb;119:104825. doi: 10.1016/j.yrtph.2020.104825. Epub 2020 Nov 19.
Regul Toxicol Pharmacol. 2021.
PMID: 33220389